1. Home
  2. VVOS vs COCP Comparison

VVOS vs COCP Comparison

Compare VVOS & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VVOS
  • COCP
  • Stock Information
  • Founded
  • VVOS 2016
  • COCP 2006
  • Country
  • VVOS United States
  • COCP United States
  • Employees
  • VVOS N/A
  • COCP N/A
  • Industry
  • VVOS Medical Specialities
  • COCP Biotechnology: Pharmaceutical Preparations
  • Sector
  • VVOS Health Care
  • COCP Health Care
  • Exchange
  • VVOS Nasdaq
  • COCP Nasdaq
  • Market Cap
  • VVOS 17.5M
  • COCP 15.4M
  • IPO Year
  • VVOS 2020
  • COCP N/A
  • Fundamental
  • Price
  • VVOS $5.24
  • COCP $1.60
  • Analyst Decision
  • VVOS Strong Buy
  • COCP Strong Buy
  • Analyst Count
  • VVOS 2
  • COCP 1
  • Target Price
  • VVOS $6.10
  • COCP $6.00
  • AVG Volume (30 Days)
  • VVOS 1.9M
  • COCP 26.7K
  • Earning Date
  • VVOS 08-13-2025
  • COCP 08-13-2025
  • Dividend Yield
  • VVOS N/A
  • COCP N/A
  • EPS Growth
  • VVOS N/A
  • COCP N/A
  • EPS
  • VVOS N/A
  • COCP N/A
  • Revenue
  • VVOS $14,628,000.00
  • COCP N/A
  • Revenue This Year
  • VVOS $3.83
  • COCP N/A
  • Revenue Next Year
  • VVOS $25.27
  • COCP N/A
  • P/E Ratio
  • VVOS N/A
  • COCP N/A
  • Revenue Growth
  • VVOS 9.47
  • COCP N/A
  • 52 Week Low
  • VVOS $1.97
  • COCP $1.12
  • 52 Week High
  • VVOS $7.95
  • COCP $3.26
  • Technical
  • Relative Strength Index (RSI)
  • VVOS 55.71
  • COCP 49.83
  • Support Level
  • VVOS $5.17
  • COCP $1.59
  • Resistance Level
  • VVOS $5.94
  • COCP $1.68
  • Average True Range (ATR)
  • VVOS 0.74
  • COCP 0.12
  • MACD
  • VVOS -0.17
  • COCP -0.01
  • Stochastic Oscillator
  • VVOS 13.97
  • COCP 28.57

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Share on Social Networks: